fusion albumin-drug conjugate targeting HER2 (IntoCell)

N/A

Report date: 2025/03/20 15:33:41

Base Information

Drug Namefusion albumin-drug conjugate targeting HER2 (IntoCell)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 modulators

TargetsReceptor protein-tyrosine kinase erbB-2

Therapy Area/IndicationsStomach NeoplasmsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesIntoCell Inc

China Registration ClassN/A

Active CompaniesIntoCell Inc

Inactive CompaniesN/A

Active IndicationsStomach NeoplasmsBreast Neoplasms

Inactive IndicationsN/A

ATC CodeN/A